← Back to Search
Technology Of Stable, Prolonged-release Eye-drops Containing Cyclosporine A, Distributed Between Lipid Matrix And Surface Of The Solid Lipid Microspheres (SLM).
E. Wolska, M. Sznitowska
Published 2013 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The aim of this study was to prepare solid lipid microspheres (SLM) with incorporated Cyclosporine A (Cs), suitable for ocular application. For this purpose, SLM were formulated by using different lipids and three different nonionic surfactants. The SLM were produced using a hot emulsification method. The SLM dispersions contained 10, 20 or 30% of lipid (w/w) and up to 2% (w/w) of Cs. The size of the microspheres with Cs ranged from 1 to 15 μm. Physically stable SLM with Cs were prepared using Compritol, as a lipid matrix, and Tween 80, as a surfactant. In contrast, dispersion with Precirol alone, formed semi-solid gels during storage, while in formulations with Precirol and Miglyol, crystals of Cs were observed. In vitro release profile of Compritol formulations showed that 40% of Cs is released within 1h, while the release of the following 40% takes more time, depending on lipid content in the formulations. The large part of Cs, added to SLM formulations (from 45 to 80%), was found on the surface of microparticles, but no drug crystallization occurred during a long-term storage.
This paper references
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets.
J. Hamdani (2003)
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
J. Pardeike (2009)
Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye
M. Guzey (2009)
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
F. Lallemand (2003)
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
E. Gokce (2008)
Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance and In Vivo Drug Release in Rabbit Eyes
E. Gökçe (2009)
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
E. Başaran (2010)
Mesoscale simulation of drug molecules distribution in the matrix of solid lipid microparticles (SLM)
C. Long (2006)
Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration
V. Sanna (2008)
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jim Jiao (2008)
Effects of Three Penetration Enhancers on Transcorneal Permeation of Cyclosporine
P. van der Bijl (2001)
The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
M. Hingorani (1999)
Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Jigisha K Varia (2008)
The size of solid lipid nanoparticles: an interpretation from experimental design.
Carla Vitorino (2011)
Topical Cyclosporin A in the Management of Therapeutic Keratoplasty for Mycotic Keratitis
H. Perry (2002)
Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
J. K. Milani (1993)
Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
Y. He (2006)
Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
B. Gebhardt (1995)
Influence of Topically Applied Cyclosporine A in Olive Oil on Corneal Epithelium Permeability
J. M. Benítez Del Castillo (1994)
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium
A. Attama (2009)
Lipid nanoparticles for the delivery of poorly water‐soluble drugs
H. Bunjes (2010)
Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye
D. Tang-Liu (2005)
Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications
S. Jaspart (2005)
The choice of lipids and surfactants for injectable extravenous microspheres.
J. Pietkiewicz (2004)
Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Jie Shen (2010)
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).
E. Ugazio (2002)
Development and Characterization of Solid-Lipid Microparticles of Highly Insoluble Drug Sirolimus
B. Nanjwade (2011)
The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates.
J. Pietkiewicz (2006)
Structural investigations on lipid nanoparticles containing high amounts of lecithin.
M. Schubert (2006)
The collagen shield. A new vehicle for delivery of cyclosporin A to the eye.
J. Reidy (1990)
Lipid microparticles as a parenteral controlled release device for peptides.
H. Reithmeier (2001)
This paper is referenced by
Ophthalmic Dosage Forms
Christian Simroth-Loch (2019)
Analytical Techniques for the Assessment of Drug-Lipid Interactions and the Active Substance Distribution in Liquid Dispersions of Solid Lipid Microparticles (SLM) Produced de novo and Reconstituted from Spray-Dried Powders
E. Wolska (2020)
TERNARY SOLID DISPERSIONS OF OMEPRAZOLE FOR ENHANCING SOLUBILITY AND DISSOLUTION
K. ArshadAhmedKhan (2015)
Design of lipid microparticle dispersions based on the physicochemical properties of the lipid and aqueous phase.
A. Lauterbach (2015)
Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.
M. Guada (2016)
Development and validation of UHPLC method for the determination of cyclosporine A in biological samples.
O. Szerkus (2014)
Ocular irritation and cyclosporine A distribution in the eye tissues after administration of Solid Lipid Microparticles in the rabbit model
E. Wolska (2018)
The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN)
M. Sznitowska (2017)
Quercetin delivery to porcine cornea and sclera by solid lipid nanoparticles and nanoemulsion
C. Liu (2015)
Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals
M. H. Aburahma (2014)
Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: development, in-vitro and in-vivo clinical evaluation
H. Gad (2017)
NOVEL APPROACHES IN THE PREPARATION OF SOLID DISPERSION ON SOLUBILITY : A REVIEW
R. Jagadeesan (2013)
Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts
F. Lallemand (2017)
Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation
Michelle L. Ratay (2017)